Laurel Wealth Advisors (California)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.1M Buy
5,745
+149
+3% +$52.8K 0.21% 115
2022
Q3
$1.81M Buy
5,596
+511
+10% +$162K 0.19% 118
2022
Q2
$1.65M Sell
5,085
-428
-8% -$128K 0.17% 135
2022
Q1
$1.58M Sell
5,513
-738
-12% -$190K 0.13% 168
2021
Q4
$1.73M Buy
6,251
+1,186
+23% +$301K 0.13% 154
2021
Q3
$1.17M Sell
5,065
-796
-14% -$196K 0.21% 110
2021
Q2
$1.35M Sell
5,861
-26
-0.4% -$5.22K 0.17% 133
2021
Q1
$1.1M Buy
5,887
+676
+13% +$132K 0.17% 149
2020
Q4
$880K Sell
5,211
-79
-1% -$11.8K 0.13% 173
2020
Q3
$783K Sell
5,290
-176
-3% -$27.2K 0.13% 175
2020
Q2
$898K Buy
5,466
+46
+0.8% +$7.06K 0.16% 139
2020
Q1
$752K Sell
5,420
-65
-1% -$8.93K 0.17% 145
2019
Q4
$721K Sell
5,485
-5,827
-52% -$675K 0.12% 192
2019
Q3
$1.26M Buy
11,312
+5,982
+112% +$666K 0.22% 125
2019
Q2
$590K Buy
5,330
+144
+3% +$17K 0.13% 175
2019
Q1
$673K Sell
5,186
-265
-5% -$32.2K 0.17% 147
2018
Q4
$630K Sell
5,451
-21
-0.4% -$2.35K 0.19% 131
2018
Q3
$587K Buy
5,472
+26
+0.5% +$2.6K 0.14% 157
2018
Q2
$464K Sell
5,446
-56
-1% -$4.6K 0.12% 189
2018
Q1
$425K Sell
5,502
-287
-5% -$23.1K 0.13% 188
2017
Q4
$488K Buy
5,789
+1,033
+22% +$87.9K 0.14% 174
2017
Q3
$406K Buy
4,756
+2
+0% +$164 0.14% 176
2017
Q2
$391K Buy
4,754
+379
+9% +$30.9K 0.14% 174
2017
Q1
$367K Sell
4,375
-867
-17% -$69.4K 0.14% 174
2016
Q4
$385K Buy
5,242
+23
+0.4% +$1.71K 0.17% 151
2016
Q3
$419K Sell
5,219
-266
-5% -$21.3K 0.2% 134
2016
Q2
$432K Hold
5,485
0.21% 123
2016
Q1
$395K Sell
5,485
-653
-11% -$49.4K 0.2% 134
2015
Q4
$517K Buy
+6,138
New +$509K 0.27% 104

Other funds holding LLY

Laurel Wealth Advisors (California)'s LLY Position: Q4 2022 in Review

Laurel Wealth Advisors (California) increased its Eli Lilly (LLY) stake by 2.7% in Q4 2022, buying an estimated $52.8K and bringing the position to 5,745 shares worth $2.1M. The position accounts for 0.21% of the portfolio, ranked #115.

Laurel Wealth Advisors (California) first reported a position in LLY in Q4 2015 and has held it in 29 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Laurel Wealth Advisors (California) held 5,745 shares of Eli Lilly worth $2.1M as of Q4 2022.
  • Laurel Wealth Advisors (California) bought 149 Eli Lilly shares in Q4 2022, an estimated $52.8K.
  • Eli Lilly made up 0.21% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #115 holding.
  • Laurel Wealth Advisors (California) first reported a position in Eli Lilly in Q4 2015 and has held it in 29 quarters since.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.